| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.00M | — |
| Operating expense | — | — |
| Net income | -111.46M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ZBIO returned +88.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -11.1% |
| 1 year | +88.8% |
| All-time high | $38.83 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ZBIO would be worth today ›No. Zenas BioPharma, Inc. has not paid a dividend in the past 12 months.
Zenas BioPharma, Inc. stock trades on NASDAQ under the ticker symbol ZBIO.
Zenas BioPharma, Inc. is part of the Healthcare sector.
Zenas BioPharma, Inc. has a market cap of 2.10B USD, based on the latest quote.
Zenas BioPharma, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
